Comparative analysis of international prognostic indices in gray-zone lymphoma.
Gray-zone lymphoma
IPI
prognosis
risk stratification
Journal
Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
pubmed:
4
12
2021
medline:
21
4
2022
entrez:
3
12
2021
Statut:
ppublish
Résumé
Gray-zone lymphoma (GZL) reflects an aggressive B-cell neoplasm with features intermediate between diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma (cHL). The International Prognostic Index (IPI) and its derivatives (R-IPI, NCCN-IPI, and the Hasenclever IPS) have been established for DLBCL or cHL while the most suitable scoring system for GZL remains undetermined. In an exploratory multi-centric cohort of GZL (
Identifiants
pubmed: 34856873
doi: 10.1080/10428194.2021.2010067
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM